Felipe Lelis
Brigham and Women's Hospital(US)Harvard University(US)GreenLight Biosciences (United States)(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Immune cells in cancer, vaccines and immunoinformatics approaches, COVID-19 Clinical Research Studies, Immune Response and Inflammation
Most-Cited Works
- → DNA vaccine protection against SARS-CoV-2 in rhesus macaques(2020)1,123 cited
- → Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity(2020)763 cited
- → Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production(2020)209 cited
- → Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike(2021)127 cited
- → Myeloid-derived suppressor cells modulate B-cell responses(2017)68 cited
- → High-throughput, targeted MHC class I immunopeptidomics using a functional genetics screening platform(2023)46 cited
- → Increase in dopaminergic, but not serotoninergic, receptors in T-cells as a marker for schizophrenia severity